METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for METASTATIC PANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo therapy for pancreatic tumors enters human trials
Disease control Recruiting nowThis early-phase trial tests whether combining two targeted drugs—sunitinib malate and lutetium Lu 177 dotatate (Lutathera)—is safe and effective for people with advanced pancreatic neuroendocrine tumors. About 24 participants will receive the combination to find the best dose an…
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy aims to shrink hard-to-treat pancreatic tumors
Disease control Recruiting nowThis early-phase study tests whether adding fulvestrant to standard radiation therapy (Lu-DOTATATE) can safely shrink tumors in people with advanced pancreatic neuroendocrine tumors that cannot be surgically removed. About 25 adults with low- or intermediate-grade tumors will rec…
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 14, 2026 12:05 UTC